CinCor Pharma Inc. (CINC) NASDAQ

$17.11 -2.22 (-11.48%)

Market Cap: $728.93M

As of 05/20/22 04:30 PM EDT. Market closed.

(CINC)

CinCor Pharma Inc. (CINC) NASDAQ

$17.11 -2.22 (-11.48%)

Market Cap: $728.93M

As of 05/20/22 04:30 PM EDT. Market closed.

COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
Full Time Employees
2,022
URL
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$18.98
Previous Close
$19.33
Days Range
$16.79 - $19.76
52 week range
$13.01 - $30.66
Volume
214,407
Avg. Volume (30 days)
119,305
Market Cap
$728.93M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
37,709,912
Open
$18.98
Previous Close
$19.33
Days Range
$16.79 - $19.76
52 week range
$13.01 - $30.66
Volume
214,407
Avg. Volume (30 days)
119,305
Market Cap
$728.93M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
37,709,912

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CINCOR PHARMA INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
GENERAL ATLANTIC GENPAR (BERMUDA), L.P. 10% Owner Jan 11, 2022 Buy $16.00 1,700,000 27,200,000 4,126,470 Jan 13, 2022, 09:32 PM
GENERAL ATLANTIC, L.P. 10% Owner Jan 11, 2022 Buy $16.00 1,700,000 27,200,000 4,126,470 Jan 13, 2022, 09:32 PM
5AM Partners VI, LLC 10% Owner Jan 11, 2022 Buy $16.00 312,500 5,000,000 496,323 Jan 13, 2022, 04:45 PM
5AM Partners VI, LLC 10% Owner Jan 11, 2022 Buy $16.00 157,500 2,520,000 3,841,323 Jan 13, 2022, 04:45 PM
Sofinnova Venture Partners X, L.P. 10% Owner Jan 11, 2022 Buy $16.00 325,000 5,200,000 5,573,949 Jan 13, 2022, 04:38 PM
Sofinnova Partners SAS 10% Owner Jan 11, 2022 Buy $16.00 220,000 3,520,000 4,087,646 Jan 13, 2022, 04:36 PM
HEALY JAMES Director Jan 11, 2022 Buy $16.00 325,000 5,200,000 5,573,949 Jan 13, 2022, 04:33 PM
Pearce Catherine Chief Operating Officer Jan 11, 2022 Buy $16.00 1,500 24,000 1,500 Jan 13, 2022, 04:31 PM
Pearce Catherine Chief Operating Officer Jan 11, 2022 Buy $16.00 750 12,000 130,911 Jan 13, 2022, 04:31 PM
Freeman Mason EVP Clinical Development Jan 11, 2022 Buy $16.00 100 1,600 100 Jan 13, 2022, 04:28 PM
Freeman Mason EVP Clinical Development Jan 11, 2022 Buy $16.00 2,500 40,000 2,500 Jan 13, 2022, 04:28 PM
de Garidel Marc Chief Executive Officer Jan 11, 2022 Buy $16.00 12,500 200,000 12,500 Jan 13, 2022, 04:26 PM
Coelho Mary Theresa EVP CFO & Chief BD Officer Jan 11, 2022 Buy $16.00 100 1,600 100 Jan 13, 2022, 04:24 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
GENERAL ATLANTIC GENPAR (BERMUDA), L.P. 10% Owner 01/11/2022 27,200,000
GENERAL ATLANTIC, L.P. 10% Owner 01/11/2022 27,200,000
5AM Partners VI, LLC 10% Owner 01/11/2022 5,000,000
5AM Partners VI, LLC 10% Owner 01/11/2022 2,520,000
Sofinnova Venture Partners X, L.P. 10% Owner 01/11/2022 5,200,000
Sofinnova Partners SAS 10% Owner 01/11/2022 3,520,000
HEALY JAMES Director 01/11/2022 5,200,000
Pearce Catherine Chief Operating Officer 01/11/2022 24,000
Pearce Catherine Chief Operating Officer 01/11/2022 12,000
Freeman Mason EVP Clinical Development 01/11/2022 1,600
Freeman Mason EVP Clinical Development 01/11/2022 40,000
de Garidel Marc Chief Executive Officer 01/11/2022 200,000
Coelho Mary Theresa EVP CFO & Chief BD Officer 01/11/2022 1,600
Load More Insider Transactions